|1.||Zhang, Lian: 3 articles (01/2015 - 01/2015)|
|2.||Chen, Siyu: 3 articles (01/2015 - 01/2015)|
|3.||Tong, Yingying: 3 articles (01/2015 - 01/2015)|
|4.||Wang, Kui: 3 articles (01/2009 - 11/2006)|
|5.||Gou, Bao-Di: 3 articles (01/2009 - 11/2006)|
|6.||Zhang, Tian-Lan: 3 articles (01/2009 - 11/2006)|
|7.||Pan, Minggui: 2 articles (01/2015 - 01/2015)|
|8.||Kim, Sungkyoung: 2 articles (01/2015 - 01/2015)|
|9.||Ding, Wenping: 2 articles (01/2015 - 01/2015)|
|10.||Zhang, Xiuli: 2 articles (01/2015 - 01/2015)|
08/01/2007 - "It is concluded that the pnas-2 gene may be closely related with apotosis of arsenic sulfide treated APL cells, and may consider as a molecular biological remission marker in acute leukemia."
02/01/2007 - "Preparation of orpiment nanoparticles and their cytotoxic effect on cultured leukemia K562 cells."
01/01/2003 - "Red orpiment inhibits the proliferation of leukemia cells by inducing them to undergo apoptosis."
11/01/2006 - "The clinical efficacy of arsenic sulfide (As(4)S(4)), also known as realgar, in the treatment of leukemia in China is prompting people to explore the underlying mechanism. "
12/01/2015 - "Prohibitin promotes apoptosis of promyelocytic leukemia induced by arsenic sulfide."
|2.||Acute Promyelocytic Leukemia
01/01/2009 - "Realgar (arsenic sulfide, As(4)S(4)) has been shown to have clinical efficacy in patients with newly diagnosed and relapsed acute promyelocytic leukemia. "
12/01/2008 - "The clinical efficacy and safety of realgar (arsenic sulfide, As(4)S(4)) in the treatment of acute promyelocytic leukemia in China have given rise to an upsurge in research on the underlying mechanism. "
08/19/2008 - "To analyze the effect of additional chromosome abnormalities on the prognosis and the clinical manifestations of acute promyelocytic leukemia (APL) and the reaction of the patients with additional chromosomes to the treatment of combination of red arsenic sulfide, all trans-retinoic acid (ATRA) and anthracyclin. "
08/19/2008 - "[Effect of additional chromosome abnormalities on the outcome of newly diagnosed acute promyelocytic leukemia treated with red arsenic sulfide and all trans-retinoic acid plus anthracyclin based protocol]."
01/01/2001 - "Arsenic compounds, Including arsenic trioxide (As2O3) and arsenic sulfide (As4S4), have recently been shown to be effective in the treatment of acute promyelocytic leukemia (APL). "
|3.||BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/01/2007 - "Thus, orpiment nanoparticles can produce a much better cytotoxic effect on cancer cells than that of traditional orpiment."
06/01/2010 - "This review primary focuses on the application of arsenic sulfide (realgar) for treatment of various forms of cancer in vitro and in vivo."
01/01/2015 - "Arsenic sulfide (As4S4), the main component of realgar, a traditional Chinese medicine, has shown antitumor efficacy in several tumor types, especially for acute promyelocytic leukemia. "
|5.||Stomach Neoplasms (Stomach Cancer)
01/01/2015 - "We previously showed that arsenic sulfide (As4S4) induced cell cycle arrest and apoptosis in several human solid tumor cell lines, including those of gastric cancer. "
01/01/2015 - "Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo."
01/01/2015 - "Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo."
|1.||arsenic disulfide (realgar)
|2.||arsenic trioxide (Trisenox)
|3.||Arsenicals (Arsenic Compounds)
|5.||Messenger RNA (mRNA)
|7.||Acetic Acid (Vinegar)
|8.||Tretinoin (Retinoic Acid)
|1.||Chinese Traditional Medicine (Traditional Chinese Medicine)
|2.||Drug Therapy (Chemotherapy)